A detailed history of Jb Capital LLC transactions in Incyte Corp stock. As of the latest transaction made, Jb Capital LLC holds 46,628 shares of INCY stock, worth $3.21 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
46,628
Previous 45,478 2.53%
Holding current value
$3.21 Million
Previous $2.76 Million 11.83%
% of portfolio
0.18%
Previous 0.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$57.33 - $68.61 $65,929 - $78,901
1,150 Added 2.53%
46,628 $3.08 Million
Q2 2024

Jul 24, 2024

BUY
$51.18 - $63.75 $59,317 - $73,886
1,159 Added 2.62%
45,478 $2.76 Million
Q1 2024

Apr 30, 2024

BUY
$56.55 - $66.59 $2.51 Million - $2.95 Million
44,319 New
44,319 $2.52 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Jb Capital LLC Portfolio

Follow Jb Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jb Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jb Capital LLC with notifications on news.